Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Bonacossa de Almeida CE"'
Publikováno v:
Pharmaceutics
Both aptamers and siRNA technologies have now reached maturity, and both have been validated with a product in the market. However, although pegaptanib reached the market some time ago, there has been a slow process for new aptamers to follow. Today,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7aa28fb52921eb79dbe2fa744ab68fac
https://pubmed.ncbi.nlm.nih.gov/31888119
https://pubmed.ncbi.nlm.nih.gov/31888119
Autor:
Bonacossa de Almeida CE; Instituto de Radioproteção e Dosimetria, Comissão Nacional de Energia Nuclear, Av. Salvador Allende 3773, Barra da Tijuca, Rio de Janeiro, RJ, 22783-127, Brazil., Harbron RW; Institute of Health & Society, Newcastle University, Sir James Spence Institute, Royal Victoria Infirmary, Newcastle upon Tyne, NE1 4LP, United Kingdom.; Radiation Protection Group, European Organisation for Nuclear Research (CERN), 1211 Geneva 23, Switzerland., Valle Bahia PR; Departamento de Radiologia, Faculdade de Medicina, Universidade Federal do Rio de Janeiro, Rua Professor Rodolpho Paulo Rocco, 255, Cidade Universitária, Rio de Janeiro, RJ, 21941-913, Brazil., Murta Dovales AC; Instituto de Radioproteção e Dosimetria, Comissão Nacional de Energia Nuclear, Av. Salvador Allende 3773, Barra da Tijuca, Rio de Janeiro, RJ, 22783-127, Brazil.
Publikováno v:
Health policy and technology [Health Policy Technol] 2023 Mar; Vol. 12 (1), pp. 100725. Date of Electronic Publication: 2023 Jan 14.
Autor:
Khan H; Department of Life, Health and Chemical Sciences, Faculty of Science, The Open University, Walton Hall, Milton Keynes MK7 6AA, UK., Makwana V; Department of Life, Health and Chemical Sciences, Faculty of Science, The Open University, Walton Hall, Milton Keynes MK7 6AA, UK., Santos SND; Radiopharmacy Department, Nuclear Energy Research Institute, São Paulo 05508-000, Brazil., Bonacossa de Almeida CE; Division of Medical Physics, Radiation Protection and Dosimetry Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 22783-127, Brazil., Santos-Oliveira R; Nuclear Engineering Institute, Brazilian Nuclear Energy Commission, Rio de Janeiro 21941-972, Brazil.; Laboratory of Radiopharmacy and Nanoradiopharmaceuticals, Zona Oeste State University, Rio de Janeiro 23070-200, Brazil., Missailidis S; Bio-Manguinhos Institute of Technology in Immunobiologics, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2021 Aug 11; Vol. 13 (8). Date of Electronic Publication: 2021 Aug 11.
Autor:
Dinis Ano Bom AP; Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz. Av. Brasil, 4365-Manguinhos, Rio de Janeiro/RJ CEP 21040-900, Brazil., da Costa Neves PC; Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz. Av. Brasil, 4365-Manguinhos, Rio de Janeiro/RJ CEP 21040-900, Brazil., Bonacossa de Almeida CE; Laboratório de Radiobiologia, Divisão de Física Médica, Instituto de Radioproteção e Dosimetria, Comissão Nacional de Energia Nuclear. Av. Salvador Allende S/N., Rio de Janeiro/RJ CEP 22783-127, Brazil., Silva D; Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz. Av. Brasil, 4365-Manguinhos, Rio de Janeiro/RJ CEP 21040-900, Brazil., Missailidis S; Instituto de Tecnologia em Imunobiológicos (Bio-Manguinhos), Fundação Oswaldo Cruz. Av. Brasil, 4365-Manguinhos, Rio de Janeiro/RJ CEP 21040-900, Brazil.
Publikováno v:
Pharmaceutics [Pharmaceutics] 2019 Dec 16; Vol. 11 (12). Date of Electronic Publication: 2019 Dec 16.